Brain death-induced inflammatory activity in human pancreatic tissue: A case-control study

Transplantation

Volumn 97, Issue 2, 2014, Pages 212-219

  Rech, Tatiana H ^a   Crispim, Daisy ^b   Rheinheimer, Jakeline ^b   Barkan, Sabrina S ^b   Osvaldt, Alessandro B ^a   Grezzana Filho, Tomaz J M ^a   Kruel, Cleber R P ^a   Martini, Juliano ^a   Gross, Jorge L ^b   Leitão, Cristiane B ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Brain death; Cytokines; Islets of Langerhans; Tissue factor

Indexed keywords

ADULT; AGED; BRAIN DEATH; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PANCREAS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84895178436     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a949fa     Document Type: Article

References (49)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
2. Hering BJ, Kandaswamy R, Ansite JD, et al. Single-donor, marginaldose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830.
3. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318.
4. Mineo D, Pileggi A, Alejandro R, et al. Point: Steady progress and current challenges in clinical islet transplantation. Diabetes Care. 2009; 32: 1563Y9.
5. Johansson H, Goto M, Dufrane D, et al. Low molecular weight dextran sulfate: A strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006; 6: 305.
6. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037.
7. Kaddis JS, Danobeitia JS, Niland JC, et al.Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes. Am J Transplant 2010; 10: 646.
8. Leitao CB, Cure P, Tharavanij T, et al. Current challenges in islet transplantation. Curr Diabetes Rep 2008; 8: 324.
9. Leitao CB, Tharavanij T, Cure P, et al. Restoration of hypoglycemia awareness after islet transplantation. Diabetes Care 2008; 31: 2113.
10. Faradji RN, Tharavanij T, Messinger S, et al. Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept. Transplantation 2008; 86: 1658.
11. Fiorina P, Shapiro AM, Ricordi C, et al. The clinical impact of islet transplantation. Am J Transplant 2008; 8: 1990.
12. Terasaki PI, Cecka JM, Gjertson DW, et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
13. Jassem W, Koo DD, Cerundolo L, et al. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation 2003; 75: 2001.
14. Jung HS, Choi SH, Kim SJ, et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors. Clin Transplant 2007; 21: 738.
15. Jin SM, Oh SH, Kim SK, et al. Diabetes-free survival in patients who underwent islet autotransplantation after 50% to 60% distal partial pancreatectomy for benign pancreatic tumors. Transplantation 2013; 95: 1396.
16. Fisher AJ, Donnelly SC, Hirani N, et al. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 1999; 353: 1412.
17. Eckhoff DE, Eckstein C, Smyth CA, et al. Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors. Surgery 2004; 136: 336.
18. Murugan R, Venkataraman R, Wahed AS, et al. Increased plasma interleukin-6 in donors is associated with lower recipient hospitalfree survival after cadaveric organ transplantation. Crit Care Med 2008; 36: 1810.
19. Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 2009; 53: 425.
20. Saito Y, Goto M, Maya K, et al. Brain death in combination with warm ischemic stress during isolation procedures induces the expression of crucial inflammatory mediators in the isolated islets. Cell Transplant 2010; 19: 775.
21. Saito Y, Goto M, Maya K, et al. The influence of brain death on tissue factor expression in the pancreatic tissues and isolated islets in rats. Transplant Proc 2009; 41: 307.
22. Adrie C, Monchi M, Fulgencio JP, et al. Immune status and apoptosis activation during brain death. Shock 2010; 33: 353.
23. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755.
24. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
25. Berman DM, Cabrera O, Kenyon NM, et al. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 2007; 84: 308.
26. Stangl M, Zerkaulen T, Theodorakis J, et al. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001; 33: 1284.
27. Birks EJ, Owen VJ, Burton PB, et al. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000; 102: 326.
28. Barthson J, Germano CM, Moore F, et al. Cytokines tumor necrosis factor-alpha and interferon-gamma induce pancreatic beta-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 2011; 286: 39632.
29. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219.
30. Ortis F, Pirot P, Naamane N, et al. Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a proapoptotic role in pancreatic beta cells. Diabetologia 2008; 51: 1213.
31. Lund T, Fosby B, Korsgren O, et al. Glucocorticoids reduce proinflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transplant Int 2008; 21: 669.
32. Hanley S, Liu S, Lipsett M, et al. Tumor necrosis factor-alpha production by human islets leads to postisolation cell death. Transplantation 2006; 82: 813.
33. Silva IA, Correia CJ, Simas R, et al. Inhibition of autonomic storm by epidural anesthesia does not influence cardiac inflammatory response after brain death in rats. Transplant Proc 2012; 44: 2213.
34. Cnop M, Welsh N, Jonas JC, et al. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes 2005; 54(Suppl 2): S97.
35. Contreras JL, Eckstein C, Smyth CA, et al. Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. Diabetes 2003; 52: 2935.
36. Kasthuri RS, Taubman MB, Mackman N. Role of tissue factor in cancer. J Clin Oncol 2009; 27: 4834.
37. Ji M, Yi S, Smith-Hurst H, et al. The importance of tissue factor expression by porcine NICC in triggering IBMIR in the xenograft setting. Transplantation 2011; 91: 841.
38. Moberg L, Olsson A, Berne C, et al. Nicotinamide inhibits tissue factor expression in isolated human pancreatic islets: Implications for clinical islet transplantation. Transplantation 2003; 76: 1285.
39. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995; 130: 966.
40. Beuneu C, Vosters O, Movahedi B, et al. Human pancreatic duct cells exert tissue factorYdependent procoagulant activity: Relevance to islet transplantation. Diabetes 2004; 53: 1407.
41. Dispoe sobre a remoçao De ó rgaos, tecidos e partes do corpo humano para fins De transplante e tratamento e dá outras providencias, Lei No. 9.434, De 4 De fevereiro De 1997 (1997).
42. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: Minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009; 55: 611.
43. Papa S, Skulachev VP. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem 1997; 174: 305.
44. Li B, Nolte LA, Ju JS, et al. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med 2000; 6: 1115.
45. Nagase I, Yoshida T, Kumamoto K, et al. Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist. J Clin Invest 1996; 97: 2898.
46. Carroll AM, Haines LR, Pearson TW, et al. Identification of a functioning mitochondrial uncoupling protein 1 in thymus. J Biol Chem 2005; 280: 15534.
47. Higuchi R, Fockler C, Dollinger G, et al. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions. Biotechnology (N Y). 1993; 11: 1026.
48. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(jDelta Delta C(T)) method. Methods 2001; 25: 402.
49. Brondani LA, De Souza BM, Duarte GC, et al. The UCP1 j3826A/G polymorphism is associated with diabetic retinopathy and increased UCP1 and MnSOD2 gene expression in human retina. Invest Ophthalmol Vis Sci 2012; 53: 7449.